미국의 유방 재건 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 형태별, 최종 용도별, 부문별 예측(2025-2030년)

U.S. Breast Reconstruction Market Growth & Trends:

The U.S. breast reconstruction market size is anticipated to reach USD 1.65 billion by 2030 and is projected to expand at a CAGR of 6.8% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing significant growth due to the increasing number of breast cancer survivors seeking reconstruction, growing awareness about breast cancer treatments, and advancements in surgical techniques. In addition, the availability of insurance coverage for reconstruction procedures and the increasing adoption of minimally invasive methods contribute to market growth. As more women undergo mastectomies and look for options to restore breast appearance, the demand for these procedures continues to rise.

New product launches and FDA approvals in the U.S. breast reconstruction market drive significant breast reconstruction advancements by promoting innovation, enhancing safety standards, and improving clinical outcomes. In October 2023, Establishment Labs announced the FDA clearance of their Motiva Flora SmoothSilk Tissue Expander, the first of its kind to receive FDA clearance in the U.S. The Motiva Flora expander eliminates the use of magnets in the filling port, making it MRI-conditional. It allows unimpeded MRI scans, crucial for post-surgical monitoring and cancer screening. This innovation by Establishment Labs has the potential to streamline the breast reconstruction process for patients who require MRI scans.

The U.S. breast reconstruction market is witnessing a significant shift toward tissue expanders as patients increasingly prefer this technology. Tissue expanders, also known as tissue expander systems, are implantable devices used to stretch and expand the skin & soft tissues in preparation for breast reconstruction surgery. This technology has gained popularity due to its ability to provide a more natural look and feel, as well as reduced recovery time & scarring. Tissue expanders are used to extend the breast pocket following a mastectomy so that a breast implant can be placed. Two-stage expander-to-implant breast reconstruction accounts for more than half of all breast reconstruction surgeries in the U.S. In the last few decades, tissue expansion technology has significantly advanced.

U.S. Breast Reconstruction Market Report Highlights:

• Based on product, the implants segment dominates the market with the largest revenue share owing to their ability to provide natural-looking results, shorter recovery times, and lower risk compared to other options like tissue flaps.
• Based on shape, the round segment dominate the market with the largest revenue share because they offer a fuller, more symmetrical appearance, which many patients prefer.
• Based on end use, the hospitals dominated the market with the largest revenue share. Hospitals perform the highest number of mastectomy and reconstruction surgeries.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Breast Reconstruction Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing awareness and acceptability of breast reconstruction among women with breast cancer
    • 3.2.1.2. Increasing number of breast reconstructive procedures
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Complications associated with implants and product recalls
• 3.3. U.S. Breast Reconstruction Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Breast Reconstruction Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Breast Reconstruction Market Product Movement Analysis
• 4.3. U.S. Breast Reconstruction Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Implants
  • 4.4.1. Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Silicone Breasts Implants
    • 4.4.2.1. Silicone Breasts Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Saline Breasts Implants
    • 4.4.3.1. Saline Breasts Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Tissue Expander
  • 4.5.1. Tissue Expander Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Saline Expander
    • 4.5.2.1. Saline Expander Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Air Tissue Expander
    • 4.5.3.1. Air Tissue Expander Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Acellular Dermal Matrix
  • 4.6.1. Acellular Dermal Matrix Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Breast Reconstruction Market: Shape Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Breast Reconstruction Market Shape Movement Analysis
• 5.3. U.S. Breast Reconstruction Market Size & Trend Analysis, by Shape, 2018 to 2030 (USD Million)
• 5.4. Round
  • 5.4.1. Round Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Anatomical
  • 5.5.1. Anatomical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Breast Reconstruction Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Breast Reconstruction Market End Use Movement Analysis
• 6.3. U.S. Breast Reconstruction Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Cosmetology Clinics
  • 6.5.1. Cosmetology Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Ambulatory Surgery Centers
  • 6.6.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. Mentor Medical Systems (Johnson & Johnson)
    • 7.2.1.1. Company Overview
    • 7.2.1.2. Financial Performance
    • 7.2.1.3. Service Benchmarking
    • 7.2.1.4. Strategic Initiatives
  • 7.2.2. Allergan, Inc. (AbbVie)
    • 7.2.2.1. Company Overview
    • 7.2.2.2. Financial Performance
    • 7.2.2.3. Service Benchmarking
    • 7.2.2.4. Strategic Initiatives
  • 7.2.3. Sientra, Inc. (Acquired by Tiger Aesthetics Medical, LLC)
    • 7.2.3.1. Company Overview
    • 7.2.3.2. Financial Performance
    • 7.2.3.3. Service Benchmarking
    • 7.2.3.4. Strategic Initiatives
  • 7.2.4. Ideal Implant, Inc. (Bimini Health Tech.)
    • 7.2.4.1. Company Overview
    • 7.2.4.2. Financial Performance
    • 7.2.4.3. Service Benchmarking
    • 7.2.4.4. Strategic Initiatives
  • 7.2.5. Establishment Labs
    • 7.2.5.1. Company Overview
    • 7.2.5.2. Financial Performance
    • 7.2.5.3. Service Benchmarking
    • 7.2.5.4. Strategic Initiatives
  • 7.2.6. RTI Surgical
    • 7.2.6.1. Company Overview
    • 7.2.6.2. Financial Performance
    • 7.2.6.3. Service Benchmarking
    • 7.2.6.4. Strategic Initiatives
  • 7.2.7. Integra LifeSciences Corporation
    • 7.2.7.1. Company Overview
    • 7.2.7.2. Financial Performance
    • 7.2.7.3. Service Benchmarking
    • 7.2.7.4. Strategic Initiatives